Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BQ323636.1, a Novel Splice Variant to NCOR 2, as a Predictor for Tamoxifen-Resistant Breast Cancer

2 Feb 2018

Abstract excerpt

Abstract Purpose: Adjuvant tamoxifen treatment revolutionized the management of estrogen receptor (ER)–positive breast cancers to prevent cancer recurrence; however, drug resistance compromises its clinical efficacy. The mechanisms underlying tamoxifen resistance are not fully understood, and no robust biomarker is available to reliably predict those who will be resistant. Here, we study BQ323636.1, a novel...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to Estrogen and related hormone effects
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29420220
DOI: 10.1158/1078-0432.ccr-17-2259

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BQ323636.1, a Novel Splice Variant to NCOR 2, as a Predictor for Tamoxifen-Resistant Breast CancerPMID 29420220Read ↗

Quercetin Suppresses TNBC Cell by Targeting ORM2Semantic proximity Read ↗

Quercetin Suppresses TNBC Cell by Targeting ORM2Semantic proximity Read ↗

NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancerSemantic proximity Read ↗

Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cellsSemantic proximity Read ↗

Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.Semantic proximity Read ↗

Identification of susceptibility loci using a novel murine model for triple-negative breast cancer.Semantic proximity Read ↗

Overcoming brain-derived therapeutic resistance in HER2+ breast cancer brain metastasisSemantic proximity Read ↗

A Novel Model of Estrogen Receptor-Positive Breast Cancer Bone Metastasis with Antiestrogen ResponsivenessSemantic proximity Read ↗

AFF3 upregulation mediates tamoxifen resistance in breast cancersSemantic proximity Read ↗

A Novel Melatonergic Signature Predicts Reccurence Risk and Therapeutic Response in Breast Cancer PatientsSemantic proximity Read ↗

Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies.Semantic proximity Read ↗

ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.